Drug Profile
Tiotropium bromide inhalation - Teva
Alternative Names: BRALTUSLatest Information Update: 28 Aug 2018
Price :
$50
*
At a glance
- Originator Teva Branded Pharmaceutical Products R&D
- Class Antiasthmatics; Antibronchitics; Epoxy compounds; Esters; Small molecules; Thiophenes; Tropanes
- Mechanism of Action Muscarinic M1 receptor antagonists; Muscarinic M3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Chronic obstructive pulmonary disease
Most Recent Events
- 28 Aug 2018 No recent reports of development identified for preclinical development in Chronic-obstructive-pulmonary-disease in USA (Inhalation, Liquid)
- 31 Aug 2016 Launched for Chronic obstructive pulmonary disease in Europe (Inhalation)
- 30 May 2016 Preregistration for Chronic obstructive pulmonary disease in European Union (Inhalation, Powder)